Trials / Completed
CompletedNCT00781859
Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.
A Randomized, Placebo Controlled, Double-masked, Multicenter Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 326 (actual)
- Sponsor
- ThromboGenics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this trial is to evaluate the safety and efficacy of intravitreal microplasmin 125µg dose in subjects wiht focal vitreomacular adhesion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 125 µg Ocriplasmin | 125µg ocriplasmin intravitreal injection |
| DRUG | Placebo | Placebo intravitreal injection |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2010-03-01
- Completion
- 2010-04-01
- First posted
- 2008-10-29
- Last updated
- 2014-12-17
- Results posted
- 2013-01-28
Locations
41 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00781859. Inclusion in this directory is not an endorsement.